Alexander Gasnash
“This government decision is crucial for the country’s pharmaceutical security. Its importance lies in the fact that all institutions will be subject to uniform operating rules and clearly defined responsibilities for all participants in the process. Thanks to this, the authorities will understand which medicines are available and where they need to intervene to prevent potential shortages,” noted Alexander Gasnash.
According to the minister, the implementation of the new system will allow for a shift from reacting to crises that have already arisen to preventing them.
“The patient should not be the first to inform the government that a certain medication is unavailable. The government must independently identify risks and intervene before the problem reaches the patient,” emphasized Gasnash.
Until now, the country has lacked a unified electronic system capable of providing comprehensive, real-time information on drug inventories. Typically, shortages of certain medications only came to light after reports from patients, pharmacies, or medical facilities.
The new platform will receive daily data on drug availability from manufacturers, importers, distributors, pharmacies, and healthcare facilities. Based on this information, authorities will be able to identify in advance which drugs are nearing critical stock levels and take the necessary measures.
The system will automatically generate alerts when stocks of specific drugs decline, create analytical reports, and provide an up-to-date overview of the situation at the national level. This will enable decision-making based on real-time and timely data.
The Agency for Medicines and Medical Devices will manage the platform. Mandatory daily reporting on stock levels will become possible once the necessary technical conditions are in place, but no later than December 31, 2026.
